Patent details

Basic Information

Publication number:

EP2217213

PCT Application Number:

US2008081496

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088444047

PCT Publication Number:

WO2009058798

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORALLY DISINTEGRATIVE DOSAGE FORM

French Title of Invention:

FORME POSOLOGIQUE SE DÉSINTÉGRANT DANS LA BOUCHE

German Title of Invention:

IM MUND ZERFALLENDE DOSIERFORM

SPC Number:

Dates

Filing date:

29/10/2008

Grant date:

24/05/2017

EP Publication Date:

18/08/2010

PCT Publication Date:

07/05/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/05/2017

EP B1 Publication Date:

24/05/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/10/2017

Expiration date:

29/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/05/2017

 

 

Name:

Johnson & Johnson Consumer Inc.

Address:

199 Grandview Road, Skillman, NJ 08558, United States (US)

Inventor

1

Name:

BUNICK, Frank

Address:

United States (US)

2

Name:

LUBER, Joseph

Address:

United States (US)

Priority

Priority Number:

983973 P

Priority Date:

31/10/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20;

Publication

European Patent Bulletin

Issue number:

201721

Publication date:

24/05/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2018	Outgoing Correspondence	1